Lennar's New Home Orders in Q4

Photo by Dillon Kydd / Unsplash

Today is Thursday, December 15, 2022.

New to this newsletter? Sign up here.

Early Bird Referral Program

1 Referral

Investing Guide With 12 Stock Picks

3 Referrals

Exclusive Community

7 Referrals

Pick a Stock Topic for a Newsletter

12 Referrals

Coffee Mug

20 Referrals

T-Shirt

40 Referrals

$100 Amazon Gift Card

Share your unique link, earn rewards

Lennar's New Home Orders in Q4

Messy financial results sent shares of homebuilder Lennar (NYSE: LEN) down 2.49% in after-hours earnings on Wednesday.

Financials: Lennar reported earnings of $5.02 per share and revenue of $10.2 billion; both were better than expected.

Big Growth: In the quarter, deliveries grew by 13% and total revenues increased by 21%.

Big Drop: The problem with Lennar’s results was that new orders decreased by 15%. Lennar’s cancellation rate also grew from 12% last year to 26% this year.

Quote: “Our sales volume and pricing have clearly been impacted by rising interest rates, but there remains a significant national shortage of housing, especially workforce housing, and there is still demand as we navigate the rebalance between price and interest rates.” - Lennar CEO Stuart Miller.

Stock Price: Shares of Lennar are down 18% this year, but are up 3% in the past 30 days.

Final Thoughts: Even though Lennar’s stock has a good price-to-earnings ratio, this isn’t a good market for homebuilders due to interest rates and macroeconomic challenges.

Notables

Notable Earnings Today: Adobe (Nasdaq: ADBE), Jabil (NYSE: JBL), Quanex Building Products (NYSE: NX), Live Ventures (Nasdaq: LIVE).

Notable IPOs Today: GE HealthCare Technologies Inc. Common Stock When-Issued (Nasdaq: GEHCV).

Notable Equity Crowdfunding Campaigns Ending Today: Day One (Republic), HANGOBI by Hang Obi (StartEngine), VORSHEER (StartEngine), SkyMirr (StartEngine), AiViva (StartEngine), Dead Lizard Brewing (Honeycomb), AiViva (StartEngine), HeatGen (StartEngine).

Notable Economic Events Today: Jobless Claims (8:30 a.m. ET), Philadelphia Fed Manufacturing Index (8:30 a.m. ET), Retail Sales / Core Retail Sales (8:30 a.m. ET), NY Empire State Manufacturing Index (8:30 a.m. ET), Philly Fed Employment (8:30 a.m. ET), Industrial Production (9:15 a.m. ET), Business Inventories (10:00 a.m. ET), Treasury International Capital (TIC) Net Long-Term Transactions (4:00 p.m. ET).

Novavax Scares Investors With Offering

Photo by Mufid Majnun / Unsplash

A new offering from Novavax (Nasdaq: NVAX) caused shares of the biotechnology company to drop 10.45% in after-hours trading on Wednesday.

Details: Novavax rolled a proposed offering of $125 million in convertible senior notes and a $125 million offering of its common stock. Investors didn’t appreciate the offerings.

Capital: Proceeds from the offerings will be used for the launch of new products, paying debt, and research and development.

Stock Price: Novavax is down 87% in 2022, including a 25% drop in the last 30 days.

Final Thoughts: Despite releasing a Covid vaccine, Novavax has struggled. This new offering is proof that the company still needs financial assistance.

Warner Bros. Discovery Sees Higher Costs

Shares of Warner Bros Discovery (Nasdaq: WBD) ticked down 0.55% in after-hours trading on Wednesday after the media company revised a previous filing.

Details: The company originally said in October that it would incur charges of $3.2 billion to $4.3 billion related to its restructuring. Now, the company anticipated restructuring charges of $4.1 billion to $5.3 billion.

Final Thoughts: Warner Bros Discovery, which is down 56% this year, could also face higher financial charges as restructuring continues to unravel.